Atlas Trials

Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Clinical trial NCT03321890 · UNKNOWN

Trial details

NCT number
NCT03321890
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Peripheral T-cell Lymphoma
Start date
2017-03-07
Primary completion
2020-12-01
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.